We are live on ! Find out more
VHAQ.WS

Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share
VHAQ.WS

Delisted

VHAQ.WS was delisted on the 23rd of October, 2023.

33 hedge funds and large institutions have $9.37M invested in Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

51% more capital invested

Capital invested by funds: $6.21M → $9.37M (+$3.16M)

3% more funds holding

Funds holding: 3233 (+1)

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

Holders
33
Holders Change
+1
Holders Change %
+3.13%
% of All Funds
0.56%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
4
Reduced
4
Closed
1
Calls
$2.46M
Puts
Net Calls
+$2.46M
Net Calls Change
+$282K
Name Holding Trade Value Shares
Change
Change in
Stake
ICMH
26
Integrity Capital Management (HK)
Hong Kong
$1K -$8.09K -106,296 -80%
OMC
27
Old Mission Capital
Illinois
$1K +$15 +200 +2%
VF
28
Virtu Financial
New York
$1K +$58 +767 +6%
Susquehanna International Group
29
Susquehanna International Group
Pennsylvania
$1K +$1.16K +15,284 New
HHGC
30
Hunting Hill Global Capital
New York
$1K +$1.41K +18,547 New
MF
31
Magnetar Financial
Illinois
-$6K -74,165 Closed
UBS Group
32
UBS Group
Switzerland
+$273 +3,591 +187%

VHAQ.WS Hedge Fund Activity: Q2 2022 in Review

33 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share (VHAQ.WS) for Q2 2022, worth a combined $9.37M — up 51% from $6.21M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new VHAQ.WS positions and 1 closed out — a net gain of 1 holder — while 4 added to existing stakes and 4 trimmed.

The largest buyer was Radcliffe Capital Management, adding an estimated $25.7K. The largest seller was Citadel Advisors, cutting an estimated $38K.

  • 33 institutional investors held Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share (VHAQ.WS) as of Q2 2022, up from 32 in Q1 2022.
  • Funds reported $9.37M of Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share stock for Q2 2022, up 51% quarter-over-quarter.
  • 2 funds opened new Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share positions in Q2 2022 and 1 closed out, a net change of +1 holder.
  • The largest Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share buyer in Q2 2022 was Radcliffe Capital Management, an estimated $25.7K added.
  • The largest Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share seller in Q2 2022 was Citadel Advisors, an estimated $38K sold.

Based on aggregated 13F filings for Q2 2022.